Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The serotonin syndrome.

H Sternbach1

  • 1Department of Psychiatry, UCLA-Neuropsychiatric Institute, Los Angeles.

The American Journal of Psychiatry
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Serotonin syndrome, a toxic condition, often results from interactions between serotonergic agents and monoamine oxidase inhibitors. Prompt recognition and treatment are crucial for patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterologous overexpression of human NEFA and studies on the two EF-hand calcium-binding sites.

Biochemical and biophysical research communications·1999
Same author

Age-associated testosterone decline in men: clinical issues for psychiatry.

The American journal of psychiatry·1998
Same author

Accuracy of protein biosynthesis: quasi-species nature of proteins and possibility of error catastrophes.

Journal of theoretical biology·1998
Same author

Antibiotics: neuropsychiatric effects and psychotropic interactions.

Harvard review of psychiatry·1998
Same author

A naturalistic pilot study comparing haloperidol, clozapine, sertindole, and risperidone in partially responsive chronic schizophrenia or schizoaffective disorder.

Journal of clinical psychopharmacology·1997
Same author

Lamotrigine treatment of refractory bipolar disorder.

The Journal of clinical psychiatry·1997

Area of Science:

  • Neuroscience
  • Clinical Pharmacology

Background:

  • Serotonin syndrome is a potentially life-threatening condition.
  • It arises from excessive serotonergic activity in the central nervous system.

Purpose of the Study:

  • To review the literature on serotonin syndrome.
  • To analyze reported cases to identify clinical features, drug interactions, incidence, treatment, and outcomes.

Main Methods:

  • Literature review.
  • Analysis of 38 case reports of serotonin syndrome in human patients.

Main Results:

  • Most commonly caused by interactions between serotonergic agents and monoamine oxidase inhibitors.
  • Key features include altered mental status, autonomic hyperactivity, and neuromuscular abnormalities.

Related Experiment Videos

  • Treatment involves discontinuing the offending agent and supportive care; 5-HT receptor antagonists may be used.

    • Conclusions:

    • Serotonin syndrome is a critical condition requiring heightened clinical awareness.
    • Further research is needed to establish diagnostic criteria, incidence, and predisposing factors.
    • Differentiating serotonin syndrome from neuroleptic malignant syndrome is important.